Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ICML 2023 | Zamtocabtagene autoleucel: mechanism of production & potential implications for access

Matthew Ulrickson • 15 Jun 2023
ICML 2023
General CAR-T Zamtocabtagene autoleucel

Matthew Ulrickson, MD, Banner MD Anderson Cancer Center, Gilbert, AZ, comments on the mechanism of production for zamtocabtagene autoleucel (zamto-cel) and explains how this may potentially improve access to this agent. This interview took place at the 17th International Conference on Malignant Lymphoma (ICML), held in Lugano, Switzerland.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

More from Matthew Ulrickson

The changing role of alloSCT in DLBCL in the era of novel agents
1:09
The changing role of alloSCT in DLBCL in the era of novel agents
Matthew Ulrickson • 15 Jun 2023
Optimizing CAR-T outcomes in DLBCL: possible combination strategies & sequencing of agents
1:09
Optimizing CAR-T outcomes in DLBCL: possible combination strategies & sequencing of agents
Matthew Ulrickson • 15 Jun 2023
Zamtocabtagene autoleucel for the treatment of patients with R/R DLBCL
1:33
Zamtocabtagene autoleucel for the treatment of patients with R/R DLBCL
Matthew Ulrickson • 15 Jun 2023

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals